• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用下一代测序技术对HIV-1中和抗体反应及病毒基因多样性进行表征。

HIV-1 neutralizing antibody response and viral genetic diversity characterized with next generation sequencing.

作者信息

Carter Christoph C, Wagner Gabriel A, Hightower George K, Caballero Gemma, Phung Pham, Richman Douglas D, Pond Sergei L Kosakovsky, Smith Davey M

机构信息

University of California San Diego, 9500 Gilman Dr. 0679, La Jolla, CA 92093, USA.

University of California San Diego, 9500 Gilman Dr. 0679, La Jolla, CA 92093, USA.

出版信息

Virology. 2015 Jan 1;474:34-40. doi: 10.1016/j.virol.2014.10.019. Epub 2014 Nov 11.

DOI:10.1016/j.virol.2014.10.019
PMID:25463602
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4259848/
Abstract

To better understand the dynamics of HIV-specific neutralizing antibody (NAb), we examined associations between viral genetic diversity and the NAb response against a multi-subtype panel of heterologous viruses in a well-characterized, therapy-naïve primary infection cohort. Using next generation sequencing (NGS), we computed sequence-based measures of diversity within HIV-1 env, gag and pol, and compared them to NAb breadth and potency as calculated by a neutralization score. Contemporaneous env diversity and the neutralization score were positively correlated (p=0.0033), as were the neutralization score and estimated duration of infection (EDI) (p=0.0038), and env diversity and EDI (p=0.0005). Neither early env diversity nor baseline viral load correlated with future NAb breadth and potency (p>0.05). Taken together, it is unlikely that neutralizing capability in our cohort was conditioned on viral diversity, but rather that env evolution was driven by the level of NAb selective pressure.

摘要

为了更好地理解HIV特异性中和抗体(NAb)的动态变化,我们在一个特征明确、未经治疗的初发感染队列中,研究了病毒基因多样性与针对多亚型异源病毒的NAb反应之间的关联。使用下一代测序(NGS)技术,我们计算了HIV-1包膜蛋白(env)、衣壳蛋白(gag)和聚合酶蛋白(pol)基于序列的多样性指标,并将其与通过中和评分计算得出的NAb广度和效力进行比较。同期的env多样性与中和评分呈正相关(p=0.0033),中和评分与估计感染持续时间(EDI)也呈正相关(p=0.0038),env多样性与EDI同样呈正相关(p=0.0005)。早期env多样性和基线病毒载量均与未来的NAb广度和效力无关(p>0.05)。综上所述,我们队列中的中和能力不太可能取决于病毒多样性,而更有可能是env进化受NAb选择压力水平的驱动。

相似文献

1
HIV-1 neutralizing antibody response and viral genetic diversity characterized with next generation sequencing.利用下一代测序技术对HIV-1中和抗体反应及病毒基因多样性进行表征。
Virology. 2015 Jan 1;474:34-40. doi: 10.1016/j.virol.2014.10.019. Epub 2014 Nov 11.
2
Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency.抗V3/聚糖和抗膜近端外部区域(MPER)中和抗体,而非抗V2/聚糖位点抗体,与更强的抗HIV-1中和广度和效力密切相关。
J Virol. 2015 May;89(10):5264-75. doi: 10.1128/JVI.00129-15. Epub 2015 Feb 11.
3
Selective increases in HIV-specific neutralizing antibody and partial reconstitution of cellular immune responses during prolonged, successful drug therapy of HIV infection.在对HIV感染进行长期、成功的药物治疗期间,HIV特异性中和抗体选择性增加,细胞免疫反应部分重建。
AIDS Res Hum Retroviruses. 2001 Jul 20;17(11):1021-34. doi: 10.1089/088922201300343708.
4
Improving neutralization potency and breadth by combining broadly reactive HIV-1 antibodies targeting major neutralization epitopes.通过组合靶向主要中和表位的广泛反应性HIV-1抗体提高中和效力和广度。
J Virol. 2015 Mar;89(5):2659-71. doi: 10.1128/JVI.03136-14. Epub 2014 Dec 17.
5
Genetic and biological properties of HIV type 1 isolates prevalent in villagers of the Cameroon equatorial rain forests and grass fields: further evidence of broad HIV type 1 genetic diversity.喀麦隆赤道雨林和草原地区村民中流行的1型人类免疫缺陷病毒(HIV-1)分离株的遗传和生物学特性:1型HIV广泛遗传多样性的进一步证据
AIDS Res Hum Retroviruses. 2003 Dec;19(12):1167-78. doi: 10.1089/088922203771881284.
6
Resistance to antibody neutralization in HIV-2 infection occurs in late stage disease and is associated with X4 tropism.HIV-2 感染中的抗体中和抗性出现在疾病晚期,与 X4 嗜性相关。
AIDS. 2012 Nov 28;26(18):2275-84. doi: 10.1097/QAD.0b013e328359a89d.
7
The Neutralizing Antibody Response in an Individual with Triple HIV-1 Infection Remains Directed at the First Infecting Subtype.一名三重感染HIV-1的个体中的中和抗体反应仍针对首次感染的亚型。
AIDS Res Hum Retroviruses. 2016 Oct/Nov;32(10-11):1135-1142. doi: 10.1089/aid.2015.0324. Epub 2016 Feb 24.
8
Dynamics of viral evolution and neutralizing antibody response after HIV-1 superinfection.HIV-1 再次感染后病毒进化和中和抗体反应的动力学。
J Virol. 2013 Dec;87(23):12737-44. doi: 10.1128/JVI.02260-13. Epub 2013 Sep 18.
9
Broad neutralizing antibody response and genetic variation in HIV-1 env genes in Koreans with primary HIV-1 infections.韩国原发性 HIV-1 感染者中 HIV-1 env 基因的广谱中和抗体反应和遗传变异。
Arch Virol. 2011 Mar;156(3):465-72. doi: 10.1007/s00705-010-0870-2. Epub 2010 Dec 24.
10
HIV-1 superinfection in women broadens and strengthens the neutralizing antibody response.HIV-1 超级感染拓宽并增强了女性体内的中和抗体反应。
PLoS Pathog. 2012;8(3):e1002611. doi: 10.1371/journal.ppat.1002611. Epub 2012 Mar 29.

引用本文的文献

1
NanoHIV: A Bioinformatics Pipeline for Producing Accurate, Near Full-Length HIV Proviral Genomes Sequenced Using the Oxford Nanopore Technology.NanoHIV:一个生物信息学管道,用于使用牛津纳米孔技术产生准确、接近全长的 HIV 前病毒基因组序列。
Cells. 2021 Sep 28;10(10):2577. doi: 10.3390/cells10102577.
2
Longitudinal Antibody Responses in People Who Inject Drugs Infected With Similar Human Immunodeficiency Virus Strains.在感染相似人类免疫缺陷病毒株的静脉注射吸毒者中观察到的抗体纵向反应。
J Infect Dis. 2020 Feb 18;221(5):756-765. doi: 10.1093/infdis/jiz503.
3
Proliferative memory SAMHD1low CD4+ T cells harbour high levels of HIV-1 with compartmentalized viral populations.增殖记忆 SAMHD1low CD4+ T 细胞携带高水平的 HIV-1,具有分隔的病毒群体。
PLoS Pathog. 2019 Jun 20;15(6):e1007868. doi: 10.1371/journal.ppat.1007868. eCollection 2019 Jun.
4
Transient and asymptomatic meningitis in human immunodeficiency virus-1 subtype C: a case study of genetic compartmentalization and biomarker dynamics.人类免疫缺陷病毒 1 型 C 亚型伴短暂无症状性脑膜炎:基因区隔化和生物标志物动态的病例研究。
J Neurovirol. 2018 Dec;24(6):786-796. doi: 10.1007/s13365-018-0672-y. Epub 2018 Sep 7.
5
The Janus Face of Follicular T Helper Cells in Chronic Viral Infections.慢性病毒感染中滤泡辅助性T细胞的双面性
Front Immunol. 2018 May 25;9:1162. doi: 10.3389/fimmu.2018.01162. eCollection 2018.
6
Size, Composition, and Evolution of HIV DNA Populations during Early Antiretroviral Therapy and Intensification with Maraviroc.早期抗逆转录病毒治疗及使用马拉维若强化治疗期间HIV DNA群体的大小、组成与演变
J Virol. 2018 Jan 17;92(3). doi: 10.1128/JVI.01589-17. Print 2018 Feb 1.
7
Brief introduction of current technologies in isolation of broadly neutralizing HIV-1 antibodies.广泛中和性HIV-1抗体分离的当前技术简介
Virus Res. 2018 Jan 2;243:75-82. doi: 10.1016/j.virusres.2017.10.011. Epub 2017 Oct 16.
8
No Substantial Evidence for Sexual Transmission of Minority HIV Drug Resistance Mutations in Men Who Have Sex with Men.无充分证据表明男男性行为者中少数HIV耐药性突变可通过性传播。
J Virol. 2017 Oct 13;91(21). doi: 10.1128/JVI.00769-17. Print 2017 Nov 1.
9
Different Somatic Hypermutation Levels among Antibody Subclasses Disclosed by a New Next-Generation Sequencing-Based Antibody Repertoire Analysis.基于新一代测序的抗体库分析揭示抗体亚类间不同的体细胞高频突变水平
Front Immunol. 2017 May 3;8:389. doi: 10.3389/fimmu.2017.00389. eCollection 2017.
10
Dynamic of CSF and serum biomarkers in HIV-1 subtype C encephalitis with CNS genetic compartmentalization-case study.HIV-1 C型脑炎合并中枢神经系统基因分区时脑脊液和血清生物标志物的动态变化——病例研究
J Neurovirol. 2017 Jun;23(3):460-473. doi: 10.1007/s13365-017-0518-z. Epub 2017 Feb 28.

本文引用的文献

1
Incidence and prevalence of intrasubtype HIV-1 dual infection in at-risk men in the United States.在美国高危男性中,亚基因型 HIV-1 双重感染的发生率和流行率。
J Infect Dis. 2014 Apr 1;209(7):1032-8. doi: 10.1093/infdis/jit633. Epub 2013 Nov 22.
2
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys.高效中和 HIV-1 特异性单克隆抗体在感染猴免疫缺陷病毒的恒河猴中的治疗效果。
Nature. 2013 Nov 14;503(7475):224-8. doi: 10.1038/nature12744. Epub 2013 Oct 30.
3
Dynamics of viral evolution and neutralizing antibody response after HIV-1 superinfection.HIV-1 再次感染后病毒进化和中和抗体反应的动力学。
J Virol. 2013 Dec;87(23):12737-44. doi: 10.1128/JVI.02260-13. Epub 2013 Sep 18.
4
Antibodies in HIV-1 vaccine development and therapy.HIV-1 疫苗开发和治疗中的抗体。
Science. 2013 Sep 13;341(6151):1199-204. doi: 10.1126/science.1241144.
5
HIV-1 neutralizing antibodies: understanding nature's pathways.HIV-1 中和抗体:理解自然途径。
Immunol Rev. 2013 Jul;254(1):225-44. doi: 10.1111/imr.12075.
6
Using ultradeep pyrosequencing to study HIV-1 coreceptor usage in primary and dual infection.应用超高深度焦磷酸测序研究原发和混合感染中 HIV-1 辅助受体的使用。
J Infect Dis. 2013 Jul 15;208(2):271-4. doi: 10.1093/infdis/jit168. Epub 2013 Apr 18.
7
HIV therapy by a combination of broadly neutralizing antibodies in humanized mice.在人源化小鼠中通过广泛中和抗体的组合进行 HIV 治疗。
Nature. 2012 Dec 6;492(7427):118-22. doi: 10.1038/nature11604. Epub 2012 Oct 24.
8
HIV-1 superinfection in women broadens and strengthens the neutralizing antibody response.HIV-1 超级感染拓宽并增强了女性体内的中和抗体反应。
PLoS Pathog. 2012;8(3):e1002611. doi: 10.1371/journal.ppat.1002611. Epub 2012 Mar 29.
9
Longitudinal analysis of early HIV-1-specific neutralizing activity in an elite neutralizer and in five patients who developed cross-reactive neutralizing activity.精英中和抗体者和五名产生交叉中和反应抗体者的 HIV-1 早期特异性中和活性的纵向分析。
J Virol. 2012 Feb;86(4):2045-55. doi: 10.1128/JVI.06091-11. Epub 2011 Dec 7.
10
Clinical, virologic, and immunologic correlates of HIV-1 intraclade B dual infection among men who have sex with men.男男性行为者中 HIV-1 内群 B 型双重感染的临床、病毒学和免疫学相关性。
AIDS. 2012 Jan 14;26(2):157-65. doi: 10.1097/QAD.0b013e32834dcd26.